Inhibition of MICA and MICB Shedding Elicits NK-Cell–Mediated Immunity against Tumors Resistant to Cytotoxic T Cells https://t.co/N8LCgtmgW8
@Biotech2k1 MICA/B can be shed (via proteolytic cleavage) resulting in escape from recognition https://t.co/FNZNQTs7yE To overcome this, $FATE's FT536 targets the (conserved) alpha-3 domain, which stabilises MICA/B on the cell surface https://t.co/tpI0fk8
How’s your day going, #AACR21❓ If you are listening in on ‘Therapeutic Mechanisms of Novel Anticancer Agents,’ you may be interested in these topic-related @CIR_AACR papers! #CancerImmunology https://t.co/jBUeUxJFo1 https://t.co/nmFqfWVZc3 https://t.co/du
ICYMI: A #MICA/#MICB antibody inhibits their proteolytic shedding, leading to #NKcell responses against tumor cells resistant to #CytotoxicTcells. This earned a #CIRReviewerStar ⭐️https://t.co/Rrauf8XXKP #panobinostat #B2M #JAK1 https://t.co/cPXuRXdWHq
A #MICA/#MICB antibody inhibits their proteolytic shedding, leading to #NKcell responses against tumor cells resistant to #CytotoxicTcells. This earned a #CIRReviewerStar ⭐️https://t.co/Rrauf9fyCn #panobinostat #B2M #JAK1 https://t.co/qLCQgts3ro
Inhibition of MICA and MICB Shedding Elicits NK cell-mediated Immunity against Tumors Resistant to Cytotoxic T cells. by Ferrari de Andrade L, Kumar S, Luoma A, Ito Y, Alves da Silva PH, Pan D, Pyrdol JW, Yoon CH, Wucherpfennig KW https://t.co/QjqDfJyxPc
RT @Fer_NK_nando: One more excellent contribution of Dr Lucas Ferrari de Andrade @IcahnMountSinai with collaborators! Good natural killer r…
One more excellent contribution of Dr Lucas Ferrari de Andrade @IcahnMountSinai with collaborators! Good natural killer read @CIR_AACR !!! https://t.co/QvJVttNFFE